We are international
Donate
• IMF TV TEXT SIZE   

Webcasts About the IMF
International Myeloma Working Group
Patient & Family Seminar Webcasts
IMF Webcasts from Medical Meetings
General Information
Nurse Leadership Board Webcasts
Teleconferences
IMF International Webcasts
Webinars
Patient Power Webcasts
Vital Options Webcasts
CancerCare Podcasts
Freelite/Hevylite
IMF Salamanca Flow Cytometry Workshop

The International Myeloma Foundation (IMF) and the EuroFlow consortium introduce a new automated and highly sensitive flow cytometry method for standardized detection of minimal residual disease (MRD) in myeloma patients.

IMWG - Report from ASH 2013 New Orleans

IMWG report from ASH 2013 New Orleans

 

4th Annual IMWG Summit: Key Questions
Stockholm report

The International Myeloma Working Group is the collaborative research body of the International Myeloma Foundation. Over 160 myeloma specialists meet annually to focus on key issues in myeloma research. The work of the IMWG has resulted in worldwide consensus on treatment protocols for myeloma patients. Going forward, the IMWG will incorporate findings from the IMF's Black Swan Research Initiative into their published guidelines.

What is the International Myeloma Working Group?
IMF's International Myeloma Working Group consists of 160 leading myeloma researchers from around the world who collaborate on a broad range of myeloma research projects. With a goal to improve myeloma treatment options and diagnostic systems, their work focuses on protocols to provide a more durable remission for myeloma patients while improving quality of life, addressing the needs of both myeloma patients and the physicians who treat them.